Cite
APA Citation
Zhang, J., Lin, Y., Sun, X. J., Wang, B. Y., Wang, Z. H., Luo, J. F., Wang, L. P., Zhang, S., Cao, J., Tao, Z. H., Wu, J., Shao, Z. M., Yang, W. T., & Hu, X. C. (2018). biomarker assessment of the CBCSG006 trial: a randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer. Annals of oncology, 29, 1741–1747. http://access.bl.uk/ark:/81055/vdc_100095501409.0x00003a